Die Oldenburgische Landesbank (OLB) hat im vergangenen Jahr offenbar einen Rekordgewinn erzielt. Dahinter standen unter ...

Die Staatsanwaltschaft Köln bereitete in den Cum-Ex Ermittlungen zur australischen Macquarie Bank erste Anklagen gegen ...

The company will not receive any proceeds from the sale of the shares by the selling stockholders. Invest with Confidence: Follow TipRanks' Top ...

Vor Biopharma Inc. (NYSE:VOR – Get Free Report) has received an average rating of “Buy” from the seven analysts that are ...

Vor Bio (NASDAQ:VOR) shares soared more than 20% in Friday pre-market trading, after it said that it has entered into a securities purchase agreement for a private investment in public equity ...

CAMBRIDGE, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced the appointment of Mr. Erez Kalir to its Board of ...

CAMBRIDGE, Mass., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it has entered into a securities purchase ...

Vor Bio (VOR) announced the appointment of Erez Kalir to its Board of Directors. The appointment represents a new seat on Vor Bio’s Board of ...

UC&C-Gipfel 2025 von Wildix stellt KI-gestützte Innovationen und vertikale Wachstumsdurchbrüche bei Unified Communications ...

Vor Bio, a clinical-stage cell and genome engineering company, has appointed Mr. Erez Kalir to its Board of Directors, creating a new seat following a recent private investment in public equity ...

Vor announced it entered into a securities purchase agreement for a private investment in public equity financing. The company expects to generate about $55.6 million in gross proceeds.

VOR opened at $1.11 on Thursday. Vor Biopharma Inc. has a one year low of $0.63 and a one year high of $3.14. The stock has a market capitalization of $76.23 million, a P/E ratio of -0.67 and a ...